Novel markers for the diagnosis and prognosis of breast cancer

A German university has found out that two proteins may serve as novel markers for the diagnosis and prognosis of breast cancer. They may be used for the determination of a patient`s prognosis and for a therapy efficacy within the scope of personalised medicine. Cost-effective breast cancer tests are possible, convenient for patients due to easy access and applicable to young and old patients. A patent license and/or research collaboration is offered to innovative pharma / biotech companies.Ref: 11 DE 0855 3N09